← Return to Trial for new epilepsy med

Discussion

Trial for new epilepsy med

Epilepsy & Seizures | Last Active: 2 days ago | Replies (13)
Comment receiving replies
@lisalucier

Hi, @cathy5161 - wondering if you're speaking about this published study in the journal Neurology:

- Updates from the First-in-human Phase 1 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of Vormatrigine in Healthy Participants (P11-4.006) https://www.neurology.org/doi/10.1212/WNL.0000000000212741

Jump to this post

Replies to "Hi, @cathy5161 - wondering if you're speaking about this published study in the journal Neurology: -..."
cathy5161 | @cathy5161 | 5 days ago

To some extent, yes. However my understanding is that the first two trials (called Power 1 and 2) have been stopped or on hold for the time being, and Praxis is prioritizing this new phase (called Radiance) which is a small eligible cohort who will all be given 30 mg for a period of 10 to 14 weeks, very closely monitored. Hence my term of guinea pigs.

VIEW AND REPLY
cathy5161 | @cathy5161 | 5 days ago

Didn't escape me that all authors of article you sent are heavily involved in or with Praxis.....

VIEW AND REPLY